MILWAUKEE (10/27/2011) - The Foundation for the Accreditation of Cellular Therapy (FACT) has awarded a three-year re-accreditation to The Medical College of Wisconsin's Blood and Marrow Transplant (BMT) program for pediatric and adult autologous and allogeneic transplantation at Children's Hospital of Wisconsin and Froedtert Hospital.
The blood stem cell collection program and cellular therapy product processing program, performed by BloodCenter of Wisconsin and the Froedtert & the Medical College cellular processing facility respectively, were also re-accredited.
The Medical College BMT program is a combined effort of the Medical College, Children's Hospital, Froedtert Hospital, and BloodCenter and has been continuously accredited by FACT since 2001.
"Our continuous re-accreditation over the last decade is a testament to the dedication and commitment of our teams at each institution who contribute to our world-class transplant program," said David Margolis, M.D, professor of pediatrics at the Medical College, and program director for the Medical College BMT Program at Children's Hospital. "Our program provides outstanding patient care, enabled by the combining the expertise and resources of the four institutions."
Accredited facilities have met rigorous standards, as defined by the leading experts in the field, including the latest knowledge in the field of stem cell transplant, and in compliance with governmental regulations.
To achieve accreditation, institutions submit documentation and are then visited on-site for inspections of all clinical care, bone marrow and peripheral blood cellular therapy product collection, and cellular product processing facilities.
Accredited facilities in the U.S. and Canada are listed on the FACT Web Site at www.factwebsite.org.